OUR RESOURCES

Optimizing Treatment Outcomes in Lung Cancer

View Details

Oncowin Head and Neck Cancer Meet - 1

View Details

Welcome Introduction

Where we are in 2022 for molecular prolifing of Head & Neck Cancers?

Panel Discussion - NACT in Head and Neck Cancer

Lung Cancer Connect 2022 - 6 March

View Details

Welcome & Introduction

Lorlatinib as front-line option in ALK+ mNSCLC

Per-operative Therapy-Neoadjuvant and Adjuvant Immunotherapy

Management of Non-Small Cell Lung Cancer

View Details

Welcome & Introduction

Segmentectony Versus Wedge Resection for Stage Non-Small Cell Lung Cancer A Meta analysis

Role of SBRT in Early Stage NSCLC

Oncology upto Date 2022

View Details

Welcome & Introduction

New Treatment approaches in HER2 +ve Metastatic Breast Cancer

Recent developments in the management of ER+ HER2 metastatic brerast cancer